Dishman Carbogen Amcis Stock Sees -7.2% Decline, Labeled 'Strong Sell' by MarketsMOJO

Dishman Carbogen Amcis, a smallcap pharmaceutical company, has seen a decline in its stock price by -7.2% on May 31st, 2024. This has been reflected in the stock call given by MarketsMOJO, which has labeled it as a 'Strong Sell'. The stock has underperformed the sector by -7.56% and has been on a consecutive fall for the last 2 days, with a decline of -10.01% in this period.

On May 31st, the stock touched an intraday low of Rs 173.1, which is a decrease of -7.63%. Additionally, Dishman Carbogen is currently trading below its 5 day, 20 day, 50 day, 100 day, and 200 day moving averages, indicating a downward trend in its stock price.

In comparison to the overall performance of the stock market, Dishman Carbogen has shown a decline of -7.12% in just one day, while the Sensex has seen a positive growth of 0.65%. Similarly, in the last month, the company's stock has fallen by -25.08%, while the Sensex has only seen a slight decline of -0.16%.

It is important to note that this article is based on factual information and does not include any external data or sources. It is not intended to provide any recommendations or predictions about the future potential of Dishman Carbogen Amcis. As a smallcap company in the pharmaceutical industry, it is important for investors to carefully consider all available information before making any investment decisions.